HEADER TRANSFERASE 02-JAN-03 1NJS TITLE HUMAN GAR TFASE IN COMPLEX WITH HYDROLYZED FORM OF 10-TRIFLUOROACETYL- TITLE 2 5,10-DIDEAZA-ACYCLIC-5,6,7,8-TETRAHYDROFOLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GAR TFASE, GART, GAR TRANSFORMYLASE, 5'- COMPND 5 PHOSPHORIBOSYLGLYCINAMIDE TRANSFORMYLASE; COMPND 6 EC: 2.1.2.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GART; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-COFACTOR ANALOGUE COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.ZHANG,J.DESHARNAIS,T.H.MARSILJE,C.LI,M.P.HEDRICK,L.T.GOOLJARSINGH, AUTHOR 2 A.TAVASSOLI,S.J.BENKOVIC,A.J.OLSON,D.L.BOGER,I.A.WILSON REVDAT 3 16-AUG-23 1NJS 1 REMARK SEQADV HETSYN REVDAT 2 24-FEB-09 1NJS 1 VERSN REVDAT 1 10-JUN-03 1NJS 0 JRNL AUTH Y.ZHANG,J.DESHARNAIS,T.H.MARSILJE,C.LI,M.P.HEDRICK, JRNL AUTH 2 L.T.GOOLJARSINGH,A.TAVASSOLI,S.J.BENKOVIC,A.J.OLSON, JRNL AUTH 3 D.L.BOGER,I.A.WILSON JRNL TITL RATIONAL DESIGN, SYNTHESIS, EVALUATION, AND CRYSTAL JRNL TITL 2 STRUCTURE OF A POTENT INHIBITOR OF HUMAN GAR TFASE: JRNL TITL 3 10-(TRIFLUOROACETYL)-5,10-DIDEAZAACYCLIC-5,6,7, JRNL TITL 4 8-TETRAHYDROFOLIC ACID JRNL REF BIOCHEMISTRY V. 42 6043 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12755606 JRNL DOI 10.1021/BI034219C REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 54999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2913 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3599 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE SET COUNT : 196 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 91 REMARK 3 SOLVENT ATOMS : 251 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.17000 REMARK 3 B22 (A**2) : -0.17000 REMARK 3 B33 (A**2) : 0.26000 REMARK 3 B12 (A**2) : -0.09000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.132 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.765 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3152 ; 0.014 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4286 ; 1.369 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 398 ; 5.978 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 524 ; 0.135 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2294 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1435 ; 0.206 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 254 ; 0.126 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 32 ; 0.183 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 15 ; 0.068 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1992 ; 0.614 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3216 ; 1.148 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1160 ; 2.146 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1070 ; 3.565 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 200 REMARK 3 ORIGIN FOR THE GROUP (A): 73.6419 17.9835 22.9917 REMARK 3 T TENSOR REMARK 3 T11: 0.0441 T22: 0.0133 REMARK 3 T33: 0.0452 T12: -0.0157 REMARK 3 T13: 0.0201 T23: 0.0095 REMARK 3 L TENSOR REMARK 3 L11: 1.6259 L22: 1.7476 REMARK 3 L33: 1.2617 L12: -0.9803 REMARK 3 L13: 0.1061 L23: 0.1421 REMARK 3 S TENSOR REMARK 3 S11: -0.0076 S12: 0.0399 S13: 0.0267 REMARK 3 S21: -0.1413 S22: 0.0124 S23: -0.2800 REMARK 3 S31: 0.0716 S32: 0.1541 S33: -0.0048 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 200 REMARK 3 ORIGIN FOR THE GROUP (A): 43.3607 41.7712 24.6335 REMARK 3 T TENSOR REMARK 3 T11: 0.1003 T22: 0.0753 REMARK 3 T33: 0.0366 T12: 0.0348 REMARK 3 T13: -0.0144 T23: 0.0046 REMARK 3 L TENSOR REMARK 3 L11: 2.8273 L22: 1.4325 REMARK 3 L33: 1.1178 L12: -1.1998 REMARK 3 L13: -0.2546 L23: 0.1093 REMARK 3 S TENSOR REMARK 3 S11: -0.0602 S12: -0.2844 S13: 0.2196 REMARK 3 S21: 0.1414 S22: 0.0931 S23: 0.0313 REMARK 3 S31: -0.2453 S32: -0.1538 S33: -0.0329 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NJS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000017931. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57912 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 41.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.880 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 25.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.91 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.60100 REMARK 200 FOR SHELL : 2.020 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB CODE 1MEJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4K, 0.2 AMMONIUM SULFATE, 50MM REMARK 280 HEPES 6.7-7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 282K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.47300 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.94600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.94600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 31.47300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 201 REMARK 465 GLU A 202 REMARK 465 GLU A 203 REMARK 465 HIS A 204 REMARK 465 HIS A 205 REMARK 465 HIS A 206 REMARK 465 HIS A 207 REMARK 465 HIS A 208 REMARK 465 HIS A 209 REMARK 465 LYS B 201 REMARK 465 GLU B 202 REMARK 465 GLU B 203 REMARK 465 HIS B 204 REMARK 465 HIS B 205 REMARK 465 HIS B 206 REMARK 465 HIS B 207 REMARK 465 HIS B 208 REMARK 465 HIS B 209 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 116 O HOH A 541 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 119 50.70 -115.63 REMARK 500 THR A 132 -150.22 -127.82 REMARK 500 ILE A 149 -60.62 -95.70 REMARK 500 ASN A 194 9.52 -61.78 REMARK 500 ASN B 13 -6.65 73.27 REMARK 500 THR B 132 -150.15 -123.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE LIGAND HAS A TRIFLUOROACETYL GROUP WHEN SYNTHESIZED AND REMARK 600 IS NAMED 10-TRIFLUOROACETYL-5,10-DIDEAZA-ACYCLIC-5,6,7,8- REMARK 600 TETRAHYDROFOLIC ACID. WHEN THE COMPOUND INTERACTS WITH REMARK 600 PROTEIN HUMAN GAR TFASE, THE KETONE GROUP IS HYDROLYZED REMARK 600 TO TWO HYDROXYL GROUPS ("GEM-DIOL"). THE HYDROLYZED FORM REMARK 600 WAS THE BINDING FORM IN THE STRUCTURE. THE HYDROLYZED REMARK 600 COMPOUND IS ONLY STABLE WHEN BOUND TO ENZYME. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 521 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 522 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 621 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KEU A 510 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KEU B 610 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MEJ RELATED DB: PDB REMARK 900 APO HUMAN GAR TFASE AT HIGH PH REMARK 900 RELATED ID: 1MEN RELATED DB: PDB REMARK 900 HUMAN GAR TFASE IN COMPLEX WITH SUBSTRATE REMARK 900 RELATED ID: 1MEO RELATED DB: PDB REMARK 900 APO HUMAN GAR TFASE AT LOW PH DBREF 1NJS A 1 203 UNP P22102 PUR2_HUMAN 808 1010 DBREF 1NJS B 1 203 UNP P22102 PUR2_HUMAN 808 1010 SEQADV 1NJS HIS A 204 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS A 205 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS A 206 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS A 207 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS A 208 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS A 209 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS B 204 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS B 205 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS B 206 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS B 207 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS B 208 UNP P22102 EXPRESSION TAG SEQADV 1NJS HIS B 209 UNP P22102 EXPRESSION TAG SEQRES 1 A 209 ALA ARG VAL ALA VAL LEU ILE SER GLY THR GLY SER ASN SEQRES 2 A 209 LEU GLN ALA LEU ILE ASP SER THR ARG GLU PRO ASN SER SEQRES 3 A 209 SER ALA GLN ILE ASP ILE VAL ILE SER ASN LYS ALA ALA SEQRES 4 A 209 VAL ALA GLY LEU ASP LYS ALA GLU ARG ALA GLY ILE PRO SEQRES 5 A 209 THR ARG VAL ILE ASN HIS LYS LEU TYR LYS ASN ARG VAL SEQRES 6 A 209 GLU PHE ASP SER ALA ILE ASP LEU VAL LEU GLU GLU PHE SEQRES 7 A 209 SER ILE ASP ILE VAL CYS LEU ALA GLY PHE MET ARG ILE SEQRES 8 A 209 LEU SER GLY PRO PHE VAL GLN LYS TRP ASN GLY LYS MET SEQRES 9 A 209 LEU ASN ILE HIS PRO SER LEU LEU PRO SER PHE LYS GLY SEQRES 10 A 209 SER ASN ALA HIS GLU GLN ALA LEU GLU THR GLY VAL THR SEQRES 11 A 209 VAL THR GLY CYS THR VAL HIS PHE VAL ALA GLU ASP VAL SEQRES 12 A 209 ASP ALA GLY GLN ILE ILE LEU GLN GLU ALA VAL PRO VAL SEQRES 13 A 209 LYS ARG GLY ASP THR VAL ALA THR LEU SER GLU ARG VAL SEQRES 14 A 209 LYS LEU ALA GLU HIS LYS ILE PHE PRO ALA ALA LEU GLN SEQRES 15 A 209 LEU VAL ALA SER GLY THR VAL GLN LEU GLY GLU ASN GLY SEQRES 16 A 209 LYS ILE CYS TRP VAL LYS GLU GLU HIS HIS HIS HIS HIS SEQRES 17 A 209 HIS SEQRES 1 B 209 ALA ARG VAL ALA VAL LEU ILE SER GLY THR GLY SER ASN SEQRES 2 B 209 LEU GLN ALA LEU ILE ASP SER THR ARG GLU PRO ASN SER SEQRES 3 B 209 SER ALA GLN ILE ASP ILE VAL ILE SER ASN LYS ALA ALA SEQRES 4 B 209 VAL ALA GLY LEU ASP LYS ALA GLU ARG ALA GLY ILE PRO SEQRES 5 B 209 THR ARG VAL ILE ASN HIS LYS LEU TYR LYS ASN ARG VAL SEQRES 6 B 209 GLU PHE ASP SER ALA ILE ASP LEU VAL LEU GLU GLU PHE SEQRES 7 B 209 SER ILE ASP ILE VAL CYS LEU ALA GLY PHE MET ARG ILE SEQRES 8 B 209 LEU SER GLY PRO PHE VAL GLN LYS TRP ASN GLY LYS MET SEQRES 9 B 209 LEU ASN ILE HIS PRO SER LEU LEU PRO SER PHE LYS GLY SEQRES 10 B 209 SER ASN ALA HIS GLU GLN ALA LEU GLU THR GLY VAL THR SEQRES 11 B 209 VAL THR GLY CYS THR VAL HIS PHE VAL ALA GLU ASP VAL SEQRES 12 B 209 ASP ALA GLY GLN ILE ILE LEU GLN GLU ALA VAL PRO VAL SEQRES 13 B 209 LYS ARG GLY ASP THR VAL ALA THR LEU SER GLU ARG VAL SEQRES 14 B 209 LYS LEU ALA GLU HIS LYS ILE PHE PRO ALA ALA LEU GLN SEQRES 15 B 209 LEU VAL ALA SER GLY THR VAL GLN LEU GLY GLU ASN GLY SEQRES 16 B 209 LYS ILE CYS TRP VAL LYS GLU GLU HIS HIS HIS HIS HIS SEQRES 17 B 209 HIS HET PO4 A 521 5 HET PO4 A 522 5 HET KEU A 510 38 HET PO4 B 621 5 HET KEU B 610 38 HETNAM PO4 PHOSPHATE ION HETNAM KEU N-{4-[(1R)-4-[(2R,4R,5S)-2,4-DIAMINO-6- HETNAM 2 KEU OXOHEXAHYDROPYRIMIDIN-5-YL]-1-(2,2,2-TRIFLUORO-1,1- HETNAM 3 KEU DIHYDROXYETHYL)BUTYL]BENZOYL}-D-GLUTAMIC ACID HETSYN KEU 10-CF3C(OH)2-DDACTHF; HYDROLYZED FORM OF 10- HETSYN 2 KEU TRIFLUOROACETYL-5,10-DIDEAZA-ACYCLIC-5,6,7,8- HETSYN 3 KEU TETRAHYDROFOLIC ACID FORMUL 3 PO4 3(O4 P 3-) FORMUL 5 KEU 2(C22 H30 F3 N5 O8) FORMUL 8 HOH *251(H2 O) HELIX 1 1 GLY A 11 ARG A 22 1 12 HELIX 2 2 VAL A 40 ALA A 49 1 10 HELIX 3 3 ASN A 57 TYR A 61 5 5 HELIX 4 4 ASN A 63 PHE A 78 1 16 HELIX 5 5 SER A 93 TRP A 100 1 8 HELIX 6 6 ASN A 119 GLY A 128 1 10 HELIX 7 7 THR A 161 SER A 186 1 26 HELIX 8 8 ASN B 13 ARG B 22 1 10 HELIX 9 9 VAL B 40 ALA B 49 1 10 HELIX 10 10 ASN B 57 TYR B 61 5 5 HELIX 11 11 ASN B 63 PHE B 78 1 16 HELIX 12 12 SER B 93 TRP B 100 1 8 HELIX 13 13 ASN B 119 GLY B 128 1 10 HELIX 14 14 THR B 161 SER B 186 1 26 SHEET 1 A 7 THR A 53 VAL A 55 0 SHEET 2 A 7 GLN A 29 SER A 35 1 N SER A 35 O ARG A 54 SHEET 3 A 7 ARG A 2 ILE A 7 1 N VAL A 3 O GLN A 29 SHEET 4 A 7 ILE A 82 LEU A 85 1 O CYS A 84 N ALA A 4 SHEET 5 A 7 MET A 104 HIS A 108 1 O LEU A 105 N LEU A 85 SHEET 6 A 7 VAL A 131 PHE A 138 -1 O THR A 135 N HIS A 108 SHEET 7 A 7 ILE A 148 PRO A 155 -1 O ILE A 149 N VAL A 136 SHEET 1 B 2 VAL A 189 LEU A 191 0 SHEET 2 B 2 ILE A 197 TRP A 199 -1 O CYS A 198 N GLN A 190 SHEET 1 C 7 THR B 53 VAL B 55 0 SHEET 2 C 7 GLN B 29 SER B 35 1 N SER B 35 O ARG B 54 SHEET 3 C 7 ARG B 2 ILE B 7 1 N VAL B 3 O GLN B 29 SHEET 4 C 7 ILE B 82 LEU B 85 1 O CYS B 84 N ALA B 4 SHEET 5 C 7 MET B 104 HIS B 108 1 O LEU B 105 N LEU B 85 SHEET 6 C 7 VAL B 131 PHE B 138 -1 O THR B 135 N HIS B 108 SHEET 7 C 7 ILE B 148 PRO B 155 -1 O VAL B 154 N THR B 132 SHEET 1 D 2 VAL B 189 LEU B 191 0 SHEET 2 D 2 ILE B 197 TRP B 199 -1 O CYS B 198 N GLN B 190 CISPEP 1 LEU A 112 PRO A 113 0 10.59 CISPEP 2 LEU B 112 PRO B 113 0 10.53 SITE 1 AC1 8 THR A 10 GLY A 11 SER A 12 ASN A 13 SITE 2 AC1 8 LYS A 170 HOH A 527 HOH A 535 HOH A 577 SITE 1 AC2 4 LYS A 157 ARG A 168 HOH A 560 HOH A 611 SITE 1 AC3 11 GLY B 11 SER B 12 ASN B 13 LEU B 14 SITE 2 AC3 11 GLN B 15 ALA B 16 LYS B 45 HIS B 174 SITE 3 AC3 11 HOH B 652 HOH B 656 HOH B 705 SITE 1 AC4 24 ARG A 64 LEU A 85 MET A 89 ARG A 90 SITE 2 AC4 24 ILE A 91 LEU A 92 VAL A 97 ASN A 106 SITE 3 AC4 24 HIS A 108 PRO A 109 GLY A 117 SER A 118 SITE 4 AC4 24 VAL A 139 ALA A 140 GLU A 141 VAL A 143 SITE 5 AC4 24 ASP A 144 HOH A 528 HOH A 529 HOH A 533 SITE 6 AC4 24 HOH A 543 HOH A 563 HOH A 565 HOH B 661 SITE 1 AC5 17 ARG B 64 MET B 89 ARG B 90 ILE B 91 SITE 2 AC5 17 LEU B 92 VAL B 97 ASN B 106 HIS B 108 SITE 3 AC5 17 PRO B 109 GLY B 117 VAL B 139 ALA B 140 SITE 4 AC5 17 GLU B 141 VAL B 143 ASP B 144 HOH B 631 SITE 5 AC5 17 HOH B 684 CRYST1 126.235 126.235 94.419 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007922 0.004574 0.000000 0.00000 SCALE2 0.000000 0.009147 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010591 0.00000